Table 3.
Age, sex distribution of patients, and RSV detection, 2017‐18
| Inpatient surveillance |
Tested n (%) |
Outpatient surveillance |
Tested n (%) |
|||
|---|---|---|---|---|---|---|
|
RSV negative n (%) |
RSV positive n (%) |
RSV negative n (%) |
RSV positive n (%) |
|||
| Age | ||||||
| 0 to <6 m | 2493 (20.5) | 1461 (49.3) | 3954 (26.2) | 157 (3.3) | 40 (9.9) | 197 (3.9) |
| 6 m to <2 y | 3456 (28.5) | 1137 (38.3) | 4593 (30.4) | 726 (15.6) | 157 (38.9) | 883 (17.5) |
| 2 to <5 y | 1365 (11.2) | 187 (6.3) | 1552 (10.3) | 579 (12.5) | 93 (23.0) | 672 (13.3) |
| 5 to <18 y | 1077 (8.8) | 49 (1.6) | 1126 (7.4) | 768 (16.6) | 19 (4.7) | 787 (15.6) |
| 18 to <65 y | 2546 (21.0) | 74 (2.5) | 2620 (17.3) | 1991 (43.0) | 74 (18.8) | 2065 (41.0) |
| 65+ y | 1175 (9.7) | 55 (1.8) | 1230 (8.1) | 405 (8.7) | 20 (4.9) | 425 (8.4) |
| Male | 6255 (53.3) | 1565 (53.9) | 7820 (53.4) | 1241 (52.7) | 160 (57.5) | 1401 (53.2) |